167 related articles for article (PubMed ID: 31678194)
1. Chemoenzymatic synthesis of ultralow and low-molecular weight heparins.
Wang T; Liu L; Voglmeir J
Biochim Biophys Acta Proteins Proteom; 2020 Feb; 1868(2):140301. PubMed ID: 31678194
[TBL] [Abstract][Full Text] [Related]
2. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins.
Xu Y; Masuko S; Takieddin M; Xu H; Liu R; Jing J; Mousa SA; Linhardt RJ; Liu J
Science; 2011 Oct; 334(6055):498-501. PubMed ID: 22034431
[TBL] [Abstract][Full Text] [Related]
3. Chemoenzymatic Synthesis of Glycosaminoglycans.
Zhang X; Lin L; Huang H; Linhardt RJ
Acc Chem Res; 2020 Feb; 53(2):335-346. PubMed ID: 31714740
[TBL] [Abstract][Full Text] [Related]
4. De novo synthesis of a narrow size distribution low-molecular-weight heparin.
Chandarajoti K; Xu Y; Sparkenbaugh E; Key NS; Pawlinski R; Liu J
Glycobiology; 2014 May; 24(5):476-86. PubMed ID: 24626379
[TBL] [Abstract][Full Text] [Related]
5. Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiation.
Hoppensteadt D; Walenga JM; Fareed J; Bick RL
Hematol Oncol Clin North Am; 2003 Feb; 17(1):313-41. PubMed ID: 12627673
[TBL] [Abstract][Full Text] [Related]
6. Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides.
Karst NA; Linhardt RJ
Curr Med Chem; 2003 Oct; 10(19):1993-2031. PubMed ID: 12871100
[TBL] [Abstract][Full Text] [Related]
7. Production and chemical processing of low molecular weight heparins.
Linhardt RJ; Gunay NS
Semin Thromb Hemost; 1999; 25 Suppl 3():5-16. PubMed ID: 10549711
[TBL] [Abstract][Full Text] [Related]
8. Analysis of heparin oligosaccharides by capillary electrophoresis-negative-ion electrospray ionization mass spectrometry.
Lin L; Liu X; Zhang F; Chi L; Amster IJ; Leach FE; Xia Q; Linhardt RJ
Anal Bioanal Chem; 2017 Jan; 409(2):411-420. PubMed ID: 27325464
[TBL] [Abstract][Full Text] [Related]
9. Quality control, safety assessment and preparation approaches of low molecular weight heparin.
Yu Y; Song Y; Zhao Y; Wang N; Wei B; Linhardt RJ; Dordick JS; Zhang F; Wang H
Carbohydr Polym; 2024 Sep; 339():122216. PubMed ID: 38823901
[TBL] [Abstract][Full Text] [Related]
10. Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities.
Lima MA; Viskov C; Herman F; Gray AL; de Farias EH; Cavalheiro RP; Sassaki GL; Hoppensteadt D; Fareed J; Nader HB
Thromb Haemost; 2013 Mar; 109(3):471-8. PubMed ID: 23329070
[TBL] [Abstract][Full Text] [Related]
11. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521
[TBL] [Abstract][Full Text] [Related]
12. Use of biosynthetic enzymes in heparin and heparan sulfate synthesis.
Chappell EP; Liu J
Bioorg Med Chem; 2013 Aug; 21(16):4786-92. PubMed ID: 23313092
[TBL] [Abstract][Full Text] [Related]
13. Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.
Xu X; Li D; Chi L; Du X; Bai X; Chi L
Carbohydr Res; 2015 Apr; 407():26-33. PubMed ID: 25701653
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.
Douaisi M; Paskaleva EE; Fu L; Grover N; McManaman CL; Varghese S; Brodfuehrer PR; Gibson JM; de Joode I; Xia K; Brier MI; Simmons TJ; Datta P; Zhang F; Onishi A; Hirakane M; Mori D; Linhardt RJ; Dordick JS
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2315586121. PubMed ID: 38498726
[TBL] [Abstract][Full Text] [Related]
15. Preparation and application of a 'clickable' acceptor for enzymatic synthesis of heparin oligosaccharides.
Cai C; Edgar K; Liu J; Linhardt RJ
Carbohydr Res; 2013 May; 372():30-4. PubMed ID: 23524108
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of low molecular weight heparins.
Casu B; Torri G
Semin Thromb Hemost; 1999; 25 Suppl 3():17-25. PubMed ID: 10549712
[TBL] [Abstract][Full Text] [Related]
17. The design and synthesis of new synthetic low-molecular-weight heparins.
Chandarajoti K; Liu J; Pawlinski R
J Thromb Haemost; 2016 Jun; 14(6):1135-45. PubMed ID: 26990516
[TBL] [Abstract][Full Text] [Related]
18. Ozonolysis of the double bond of the unsaturated uronate residue in low-molecular-weight heparin and K5 heparosan.
Masuko S; Higashi K; Wang Z; Bhaskar U; Hickey AM; Zhang F; Toida T; Dordick JS; Linhardt RJ
Carbohydr Res; 2011 Sep; 346(13):1962-6. PubMed ID: 21742314
[TBL] [Abstract][Full Text] [Related]
19. An update on heparins at the beginning of the new millennium.
Fareed J; Hoppensteadt DA; Bick RL
Semin Thromb Hemost; 2000; 26 Suppl 1():5-21. PubMed ID: 11011802
[TBL] [Abstract][Full Text] [Related]
20. Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterization.
Li G; Steppich J; Wang Z; Sun Y; Xue C; Linhardt RJ; Li L
Anal Chem; 2014 Jul; 86(13):6626-32. PubMed ID: 24905078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
